SCRANTON, PA — For tens of millions of Americans, taking a prescription medication begins with a challenge most people take for granted: opening and closing the child-resistant bottle. Now, a new solution represents the first meaningful advancement in medication access in decades for consumers with disabilities.
Traditional child-resistant prescription vials require users to push down and twist the cap at the same time. This can be a significant obstacle for people living with arthritis, multiple sclerosis, Parkinson's disease, fibromyalgia or other conditions affecting dexterity. Those challenges can be even greater for people without the use of one hand or arm, including amputees and those affected by stroke or other forms of paralysis.
Now available at independent pharmacies nationwide, as well as directly to consumers via an online store, SnapSlide is an attempt to address this longstanding medication access inequity. Rather than reinventing the prescription bottle itself, SnapSlide amounts to a reengineering of what has long been considered its weakest link: the child-resistant cap. Designed to be opened, closed and used with one hand, SnapSlide replaces the traditional push-and-twist motion with a single-handed sliding mechanism that still maintains official levels of child resistance.
The closure remains attached to the vial – offering easy dosage and spillage prevention – and an audible, namesake "snap" provides confirmation that the vial is securely closed and child-resistant.
"We tend to think of opening a prescription bottle as a two-second task. But if you have arthritis, have had a stroke, lost the use of an arm or simply can't generate the strength needed to push and twist, that two-second task can become a daily obstacle," said Rocky Batzel, inventor and CEO of SnapSlide. "We wanted to rethink the bottle around the person taking the medication - not around the package. What resulted was a simple, long overdue fix that should have been adopted years ago."
Notably, SnapSlide’s potential appeal extends beyond people with physical limitations. In focus groups, nearly 90% of participants preferred the SnapSlide vial to conventional amber prescription vials. Considering this, the design meets the needs of those who struggle to open and close conventional vials, even while being more attractive to those without dexterity issues. The result is an innovation that straddles a unique intersection: “Better for all, life-changing for many.”
The nationwide expansion follows SnapSlide's initial introduction through independent pharmacies in several states, where owners reported strong interest from consumers who face difficulty using traditional prescription vial closures. Public enthusiasm has also manifested in social media, where SnapSlide accrued more than 100,000 followers on Facebook alone as the company prepared for the product’s full launch.
SnapSlide has received official praise from pharmaceutical, plastics and packaging trade organizations. It earned Gold in the Pharmaceutical and Nutraceutical category at the 2026 National Association of Container Distributors Packaging Awards and, earlier, claimed two awards from the Institute of Packaging Professionals. Testament to SnapSlide’s lower-material, low-profile design that makes it 27% lighter than conventional push-and-twist caps, it also received the 2025 Plastics Industry Association People's Choice Award for Sustainability Innovation.
